Aluma Endovascular Systems

Develops advanced laser energy delivery systems featuring a unique fiber composition integrated into catheters to address chronic disease in small arteries.

Health Tech & Life Sciences
Active
Seed Or Yehuda, Israel Founded 2025
Last updated 2026-07-20
Total raised
Last: Undisclosed Round 2025-10
Stage
Seed
Founded
2025
Headcount
5
HQ
Or Yehuda, Israel
Sector
Health Tech & Life Sciences

About

ALUMA Endovascular Systems develops advanced laser energy delivery systems featuring a unique fiber composition integrated into catheters. This technology is intended to deliver highly localized, high-energy laser pulses directly to targeted areas, overcoming the power limitations of existing solutions. The company's innovation initially addresses a significant unmet medical need affecting millions of patients with chronic disease in small arteries, a condition with limited treatment options and high morbidity and mortality rates. ALUMA was founded in collaboration with Elbit Systems, leveraging combined expertise in laser science and electro-optics, and Shaare Zedek Scientific Ltd. (Mada'it), the research and innovation branch of Shaare Zedek Medical Center in Jerusalem. This partnership blends technological and clinical expertise to serve as the foundation for ongoing innovation.

Funding history · 2 rounds · — total

2025-09
Seed Undisclosed
★ Peregrine Ventures
2025-08
Pre-Seed Undisclosed
★ Peregrine Ventures

Headcount over time

From 1 (2025-09) to 5 (2026-04) · +4 (+400%) · 2 points · source: Finder history + radar grounding
50 2025-09 2026-04

Q&A

What is Aluma Endovascular Systems' primary focus?
Aluma Endovascular Systems develops advanced laser energy delivery systems with proprietary fiber technology integrated into catheters, designed to deliver highly localized, high-energy laser pulses to targeted areas.
What medical need does Aluma Endovascular Systems' technology initially address?
The company's innovation initially addresses chronic disease in small arteries, a condition affecting millions of patients with limited treatment options and high morbidity and mortality rates.
When was Aluma Endovascular Systems founded?
Aluma Endovascular Systems was founded in August 2025.
With which organizations did Aluma Endovascular Systems collaborate for its founding?
Aluma Endovascular Systems was founded in collaboration with Elbit Systems and Shaare Zedek Scientific Ltd. (Mada’it).
Who is the Co-Founder and CEO of Aluma Endovascular Systems?
Ori Kanner is the Co-Founder & CEO of Aluma Endovascular Systems.
How many employees does Aluma Endovascular Systems currently have?
Aluma Endovascular Systems has 1-10 employees.
Which investor participated in Aluma Endovascular Systems' funding rounds in September and October 2025?
Peregrine Ventures participated in Aluma Endovascular Systems' funding rounds in September and October 2025.
What is the current product stage of Aluma Endovascular Systems?
Aluma Endovascular Systems is currently in the R&D product stage.

Team · 1

Ori Kanner
Founder · CEO & Co-Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Legal nameALUMA ENDOVASCULAR SYSTEMS LTD
Founded2025-8
Employees (exact)5

Radar intelligence

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)517210597
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2025-08-26
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Active charges / liens1
Registry events5 — people (2), other (1), charge (1), shares_capital (1)
Registered addressנתניהו יהונתן 6 אור יהודה

Recent registry events

DateEvent
2026-04-30עדכון דירקטורים-הוספת דירקטור
2025-11-26שינוי בתקנון
2025-10-26עדכון בעלי תפקידים
2025-10-19רישום שעבוד
2026-01-11הקצאת מניות